Compare
LH vs CVS vs CI vs DGX
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| LH | CVS | CI | DGX | |
|---|---|---|---|---|
| Price | $366.57 | $83.85 | $293.59 | $255.63 |
| 1-day | +0.90% | +3.10% | -2.62% | +0.35% |
| YTD | +46.11% | +5.66% | +6.67% | +47.31% |
| 1 year | +46.22% | +6.75% | +13.10% | +43.40% |
| 3 years | +79.74% | +22.00% | -5.11% | +92.88% |
| Market cap | $29.8B | $107.3B | $77.4B | $28.1B |
| P/E | 30.1 | 9.7 | 12.9 | 25.5 |
| P/S | 2.04 | 0.26 | 0.27 | 2.38 |
| P/B | 3.36 | 1.33 | 1.78 | 3.69 |
| Revenue growth | +6.00% | +6.70% | +6.80% | +9.10% |
| EPS growth | +19.60% | +2107.70% | +0.30% | +17.80% |
| Gross margin % | 29.0 | 44.2 | 20.7 | 33.1 |
| Net margin % | 6.9 | 2.6 | 2.1 | 9.5 |
| ROE % | 11.3 | 13.7 | 13.8 | 14.8 |
| Debt / equity | 0.66 | 0.75 | 0.72 | 0.73 |
| FCF yield % | 4.3 | 14.5 | 12.2 | 4.9 |
| Dividend yield % | 0.79 | 3.17 | 2.11 | 1.32 |
| Beta | 0.38 | -0.06 | 0.08 | -0.05 |
| RSI (14) | 69.9 | 39.9 | 49.6 | 66.9 |
| Technical rating |